We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.33B
AUM Growth
+$413M
Cap. Flow
+$332M
Cap. Flow %
24.95%
Top 10 Hldgs %
26.03%
Holding
123
New
17
Increased
53
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$27.7M
2
SNDK
SANDISK CORP
SNDK
+$26.1M
3
STLD icon
Steel Dynamics
STLD
+$19.7M
4
XPO icon
XPO
XPO
+$19.4M
5
MBLY
Mobileye N.V.
MBLY
+$19.2M

Top Sells

Rank Stock Value
1
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$20.4M
2
LYB icon
LyondellBasell Industries
LYB
+$10.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.3M
4
PCYC
PHARMACYCLICS INC
PCYC
+$10.1M
5
MEOH icon
Methanex
MEOH
+$9.23M

Sector Composition

Rank Sector Weight
1 Healthcare 25.62%
2 Technology 20.76%
3 Consumer Discretionary 14.72%
4 Industrials 11.01%
5 Energy 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNDK
26
DELISTED
SANDISK CORP
SNDK
$20.5M 1.54%
+321,800
New +$26.1M
NRG icon
27
NRG Energy
NRG
$28.3B
$20.4M 1.53%
808,100
+342,800
+74% +$8.66M
CCI icon
28
Crown Castle
CCI
$33.4B
$19.9M 1.5%
241,300
+110,600
+85% +$9.42M
FPRX
29
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$19.2M 1.44%
839,400
+55,400
+7% +$1.4M
SPLK
30
DELISTED
Splunk Inc
SPLK
$18.8M 1.41%
317,100
+160,700
+103% +$9.71M
CPN
31
DELISTED
Calpine Corporation
CPN
$18.4M 1.38%
803,600
+166,300
+26% +$3.59M
CMRX
32
DELISTED
Chimerix, Inc.
CMRX
$16.8M 1.26%
444,500
+25,900
+6% +$1.03M
CBI
33
DELISTED
Chicago Bridge & Iron Nv
CBI
$15.9M 1.2%
323,100
+61,100
+23% +$2.57M
NVAX icon
34
Novavax
NVAX
$1.22B
$15.8M 1.19%
95,435
– –
AGIO icon
35
Agios Pharmaceuticals
AGIO
$1.95B
$15.7M 1.18%
166,200
-92,000
-36% -$10.3M
EXR icon
36
Extra Space Storage
EXR
$31.3B
$15.6M 1.17%
+230,900
New +$15.1M
IDTI
37
DELISTED
Integrated Device Technology I
IDTI
$15.5M 1.17%
+776,100
New +$15.3M
PTLA
38
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$15.4M 1.16%
405,300
+32,900
+9% +$1.13M
TSLA icon
39
Tesla
TSLA
$1.22T
$15.3M 1.15%
1,215,000
+553,500
+84% +$7.47M
IPHI
40
DELISTED
INPHI CORPORATION
IPHI
$14.2M 1.07%
799,100
+51,700
+7% +$971K
PFPT
41
DELISTED
Proofpoint, Inc.
PFPT
$14.2M 1.07%
+239,900
New +$12.9M
LLTC
42
DELISTED
Linear Technology Corp
LLTC
$13.7M 1.03%
292,600
– –
EOG icon
43
EOG Resources
EOG
$77.5B
$13.3M 1%
144,800
– –
MGNX icon
44
MacroGenics
MGNX
$240M
$13.1M 0.98%
416,300
+205,300
+97% +$6.96M
STKL
45
DELISTED
SunOpta
STKL
$13M 0.98%
1,226,700
+377,100
+44% +$4.13M
LUMO
46
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$11.8M 0.89%
23,967
– –
VCYT icon
47
Veracyte
VCYT
$4.77B
$11M 0.83%
1,517,500
+133,400
+10% +$1.09M
CXP
48
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$10.6M 0.8%
393,800
– –
TTPH
49
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$10.6M 0.8%
14,500
– –
UFS
50
DELISTED
DOMTAR CORPORATION (New)
UFS
$10.1M 0.76%
218,600
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Eventide Asset Management held 123 positions worth $1.33B, up 45% from $916M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $332M of net new capital in Q1 2015, opening 17 new positions and adding to 53 existing holdings. Its largest new stake was Lam Research: 3,509,000 shares worth $24.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $10.3M trimmed.

  • Eventide Asset Management's largest Q1 2015 buy was Lam Research: 3,509,000 shares worth $24.6M.
  • Eventide Asset Management added most to XPO in Q1 2015, an estimated $19.4M increase.
  • Eventide Asset Management's biggest Q1 2015 reduction was Agios Pharmaceuticals, cutting an estimated $10.3M.
  • Eventide Asset Management fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q1 2015, selling an estimated $20.4M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.33B portfolio in Q1 2015.
  • Eventide Asset Management opened 17 new positions and closed 12 in Q1 2015.
  • Eventide Asset Management's portfolio value rose 45% quarter-over-quarter to $1.33B.

Based on Eventide Asset Management's 13F filing for Q1 2015, filed 14 May 2015.